Brief: Xilio Therapeutics Q4 Net Income USD -13.093 Million
11/03/2025 11:31
Mar 11 (Reuters) - Xilio Therapeutics Q4 income from operations USD -13.629 million. Q4 basic EPS USD -0.2 Q4 operating expenses USD 15.353 million
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla